Form 8-K - Current report:
SEC Accession No. 0001628280-22-026738
Filing Date
2022-10-20
Accepted
2022-10-20 11:21:06
Documents
12
Period of Report
2022-10-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K csbr-20221020.htm   iXBRL 8-K 52989
  Complete submission text file 0001628280-22-026738.txt   188812

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT csbr-20221020.xsd EX-101.SCH 1930
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT csbr-20221020_lab.xml EX-101.LAB 23832
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT csbr-20221020_pre.xml EX-101.PRE 12530
6 EXTRACTED XBRL INSTANCE DOCUMENT csbr-20221020_htm.xml XML 10837
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-11504 | Film No.: 221320406
SIC: 2836 Biological Products, (No Diagnostic Substances)